AKT1 and Alzheimer disease: Indeed, dysregulation of Rac and/or Rho GTPase has been reported in a variety of neurodegenerative diseases and neuronal traumas, including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), ischemia/reperfusion, amongst many others.